Literature DB >> 2491625

Antigen presenting cells in liver biopsies from patients with primary biliary cirrhosis.

G Ballardini1, M Fallani, F B Bianchi, E Pisi.   

Abstract

Although Langerhans, interdigitating and follicular dendritic cells have been occasionally identified in pathological human liver by ultrastructural morphology, no data are available on their phenotypical their phenotypical identification using monoclonal antibodies. Frozen normal liver samples and biopsies from patients with primary biliary cirrhosis, primary sclerosing cholangitis and chronic active hepatitis were studied using a panel of 12 monoclonal antibodies (including anti class II antigens, follicular dendritic, macrophage and Langerhans cells). In normal liver, class II positive cells were represented by Kupffer and portal tract histiocytes with a macrophage phenotype. In pathological portal tracts non lymphocytic class II positive cells were represented by macrophages, clusters of follicular dendritic cells (which were detected in close association with B cell aggregates), and by sparse Langerhans cells (localized in areas of piecemeal necrosis and in a periductal position or infiltrating class II positive bile ducts). The present data suggest that both classical antigen presenting cells and class II positive bile duct cells may play some role in the induction of autoimmune reactions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491625     DOI: 10.3109/08916938909019962

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

1.  Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).

Authors:  K Yamamoto; S M Akbar; T Masumoto; M Onji
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 2.  Human dendritic cells and transplant outcome.

Authors:  Mario G Solari; Angus W Thomson
Journal:  Transplantation       Date:  2008-06-15       Impact factor: 4.939

Review 3.  Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases.

Authors:  Haiyan Zhang; Francesca Bernuzzi; Ana Lleo; Xiong Ma; Pietro Invernizzi
Journal:  Mediators Inflamm       Date:  2015-06-04       Impact factor: 4.711

Review 4.  Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.

Authors:  Chang Wang; Ying Shi; Xiaomei Wang; Heming Ma; Quan Liu; Yanhang Gao; Junqi Niu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.